183 related articles for article (PubMed ID: 37462387)
21. Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments.
Li S; Li H; Yin D; Xue X; Chen X; Li X; Li J; Yi Y
Front Biosci (Landmark Ed); 2022 Jan; 27(1):25. PubMed ID: 35090330
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
23. Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation.
Han X; Huang J; Lu J; He F; Wang F; Li S; Zhong H; Yu H; Pu W
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1943-1955. PubMed ID: 36869905
[TBL] [Abstract][Full Text] [Related]
24. A network pharmacology approach to evaluate the synergistic effect of dihydromyricetin and myricitrin in vine tea on the proliferation of B16F10 cells.
Zhao N; Kong H; Liu H; Shi Q; Qi X; Chen Q
Front Nutr; 2022; 9():993133. PubMed ID: 36185647
[TBL] [Abstract][Full Text] [Related]
25. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
26. [Molecular mechanism of Puerariae Lobatae Radix in treatment of hepatocellular carcinoma based on network pharmacology].
Min Z; Yuan Z; Ye C; Nan XU; Wei-Bing LI; Cheng-Yu WU; Yan C
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4089-4098. PubMed ID: 33164393
[TBL] [Abstract][Full Text] [Related]
27. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
Yang L; Hu Y; Zhou G; Chen Q; Song Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
[TBL] [Abstract][Full Text] [Related]
29. A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.
Tan X; Ma X; Dai Y; An J; Yu X; Li S; Liao Y; Pei T; Tang Y; Gui Y; Zhou S; Guo D; Deng Y; Hu K; Wang D
Phytomedicine; 2023 Nov; 120():155031. PubMed ID: 37666060
[TBL] [Abstract][Full Text] [Related]
30. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
31. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
33. Anti-cancer effects of ethanol extract of Reynoutria japonica Houtt. radix in human hepatocellular carcinoma cells via inhibition of MAPK and PI3K/Akt signaling pathways.
Kim BR; Ha J; Lee S; Park J; Cho S
J Ethnopharmacol; 2019 Dec; 245():112179. PubMed ID: 31445130
[TBL] [Abstract][Full Text] [Related]
34. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
35. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways.
Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF
World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323
[TBL] [Abstract][Full Text] [Related]
36. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract][Full Text] [Related]
37. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma.
Zhang Z; Yan Z; Yuan Z; Sun Y; He H; Mai C
Tumour Biol; 2015 Mar; 36(3):1503-9. PubMed ID: 25537088
[TBL] [Abstract][Full Text] [Related]
38. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
39. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
[TBL] [Abstract][Full Text] [Related]
40. Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology.
Chen Y; Li Q; Ren S; Chen T; Zhai B; Cheng J; Shi X; Song L; Fan Y; Guo D
J Zhejiang Univ Sci B; 2022 Aug; 23(8):682-698. PubMed ID: 35953761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]